JOHNSON JENNIFER M 4

What Happened

• Jennifer M. Johnson, a Thermo Fisher Scientific (TMO) director, was credited with 60.91 deferred stock units as an award under the company's Deferred Compensation Plan for Directors on June 27, 2026. The units were valued at $513.03 each, totaling about $31,249. This transaction is an award/grant (code A) of a derivative interest (stock units), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-27; Form 4 filed: 2026-06-30.
• Amount: 60.91 deferred stock units at $513.03 per unit; total value ≈ $31,249.
• Security type: Deferred common stock units (derivative) convertible into common stock on a 1-for-1 basis (Footnote F1).
• Plan details: Units were credited under the Issuer's Deferred Compensation Plan for Directors; directors' retainers are deferred quarterly into stock units based on quarter-end closing price. Units are distributable as shares upon cessation of director service or a change of control (Footnote F2).
• Shares owned after transaction: Not specified on this filing.
• Filing timeliness: Form 4 was filed on 2026-06-30 (within the typical two-business-day reporting window for a 6/27 transaction).

Context

• This was an award of deferred stock units (compensation) rather than a market buy or sale; such grants are routine for directors and reflect compensation deferral, not a direct signal of buying/selling intent.
• The filing includes a remark that the reporting person is affiliated with Franklin Resources/Franklin Templeton and disclaims beneficial ownership of securities held by Franklin-managed accounts; this pertains to separate institutional holdings, not the deferred units reported here.